An Emerging Role of Extracellular Traps in Chronic Rhinosinusitis.
Zhang. Siyuan S; Wang. Zhenlin Z
Key Findings
- LL-37 promotes the formation of neutrophil extracellular traps (NETs) in nasal polyps of CRS patients.
- Increased NETs are found especially in sub‑epithelial areas with epithelial barrier defects.
- Higher NETs correlate with elevated IL‑5 levels and Staphylococcus aureus colonization.
Practical Outcomes
- For self‑experimenters, the main takeaway is that boosting LL-37 (e.g., via vitamin D or certain supplements) might unintentionally increase inflammatory NET formation in the sinuses, potentially worsening chronic sinus issues. There is no clear protocol or dosage recommendation for using LL-37 to improve health, and caution is advised if targeting this peptide for immune support.
Summary
The paper explains that a protein called LL-37, which is part of our innate immune system, can trigger the release of web‑like DNA structures (NETs) from immune cells in the nose of people with chronic sinus inflammation. These structures can help fight infections but also worsen inflammation and tissue damage. The study mainly describes this process in patients with nasal polyps and links it to higher levels of certain immune signals and bacterial colonization.
Abstract
Chronic rhinosinusitis (CRS) is a complicated, heterogeneous disease likely caused by inflammatory and infectious factors. There is clear evidence that innate immune cells, including neutrophils and eosinophils, play a significant role in CRS. Multiple immune cells, including neutrophils and eosinophils, have been shown to release chromatin and granular proteins into the extracellular space in response to triggering extracellular traps (ETs). The formation of ETs remains controversial due to their critical function during pathogen clearance while being associated with harmful inflammatory illnesses. This article summarizes recent research on neutrophil extracellular traps (NETs) and eosinophil extracellular traps (EETs) and their possible significance in the pathophysiology of CRS. A novel type of programmed cell death called ETosis, which releases ETs, has been proposed by recent study. Significantly more NETs are presented in nasal polyps, and its granule proteins LL-37 induce NETs production in CRS with nasal polyps (CRSwNP) patients. Similar to NETs, developed in the tissue of nasal polyps, primarily in subepithelial regions with epithelial barrier defects, and are associated with linked to elevated tissue levels of IL-5 and S. aureus colonization. This article provides a comprehensive overview of NETs and EETs, as well as an in-depth understanding of the functions of these ETs in CRS.
Study Information
pubmed
2023
2023-11-07T00:00:00.000Z
10.1007/s11882-023-01082-1
4
132